John Vivian
Bioinformatics PhD from UC Santa Cruz under David Haussler and Benedict Paten at the Genomics Institute. During my thesis work I helped develop Toil, an open-source distributed workflow system designed for massive scalability and a Bayesian method for identifying gene expression outliers in individual patient samples. I then worked on neoplastic antibody therapeutics at Atreca, specializing in RNA-seq, scRNA-seq, software architecture, data visualization, and statistical analysis. I have also contracted with several startups for bioinformatics and statistical expertise, analysis, development, and AWS infrastructure.
I am currently serving as a Principal Research Scientist, specializing in bioinformatics, at Ideaya Biosciences. My work focuses on leveraging synthetic lethality to develop innovative treatments aimed at specific cancer vulnerabilities.
I am also presently collaborating on a research paper with a colleague at the US Treasury Department. Our focus is on modeling the economic impacts of Covid-19 by examining variations in state pandemic responses. Leveraging advanced statistical methodologies such as Bayesian Dynamic Factor and Synthetic Control Models, we aim to provide a comprehensive analysis of the intricate interplay between health and economic dynamics during this challenging period